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Mutations in presenilins (PS) are the major cause of
familial Alzheimer’s disease (FAD) and have been as-
sociated with calcium (Ca2+) signaling abnormalities.
Here, we demonstrate that FAD mutant PS1 (M146L)
and PS2 (N141I) interact with the inositol 1,4,5-tri-
sphosphate receptor (InsP3R) Ca
2+ release channel
and exert profound stimulatory effects on its gating
activity in response to saturating and suboptimal
levels of InsP3. These interactions result in exagger-
ated cellular Ca2+ signaling in response to agonist
stimulation as well as enhanced low-level Ca2+
signaling in unstimulated cells. Parallel studies in
InsP3R-expressing and -deficient cells revealed that
enhanced Ca2+ release from the endoplasmic reticu-
lum as a result of the specific interaction of PS1-
M146L with the InsP3R stimulates amyloid beta pro-
cessing, an important feature of AD pathology. These
observations provide molecular insights into the
‘‘Ca2+ dysregulation’’ hypothesis of AD pathogene-
sis and suggest novel targets for therapeutic inter-
vention.
INTRODUCTION
Alzheimer’s disease (AD) is a common dementia involving slowly
developing and ultimately fatal neurodegeneration. Most AD is
sporadic and usually develops at age >60, but10% of AD is in-
herited as an autosomal-dominant trait (familial AD, FAD) and
disease develops as early as the late 30 years of age. Mutations
in amyloid precursor protein (APP) and presenilins (PS1, PS2)
cause early onset FAD (Hutton and Hardy, 1997). Hallmark fea-
tures of AD include accumulations of extracellular b amyloid
(Ab) plaques and intracellular neurofibrillary tangles with neuro-
nal atrophy or loss (Hardy, 2006; Mattson, 2004). The ‘‘amyloid
hypothesis’’ of AD postulates that accumulation of oligomericor fibrillar Ab, due to production of more amyloidogenic forms
of Ab and defective processing and clearance, leads to patho-
logical sequelae associated with the disease (Haass and Selkoe,
2007; Hardy and Selkoe, 2002). This hypothesis has neverthe-
less been questioned (De Strooper, 2007; Hardy and Selkoe,
2002; Shen and Kelleher, 2007), and others have also been pro-
posed to describe pathological origins of the disease (reviewed
in Blennow et al., 2006; Mattson, 2004). Accumulating evidence
suggests that sustained disruption of intracellular Ca2+ signaling
may play an early proximal, and perhaps central, role in AD path-
ogenesis (Gandy et al., 2006; LaFerla, 2002; Mattson and Chan,
2003; Smith et al., 2005a; Stutzmann, 2005). Ca2+ is involved in
many facets of neuronal physiology, including activity, growth
and differentiation, synaptic plasticity, and learning and memory,
as well as pathophysiology, including necrosis, apoptosis, and
degeneration (Berridge et al., 2000). Before identification of PS,
Ito (Ito et al., 1994) discovered that fibroblast lines derived
from AD patients, later shown to harbor the A246Q mutation in
PS1, without exception, generated exaggerated intracellular
Ca2+ concentration ([Ca2+]i) responses to submaximal concen-
trations of two G protein-coupled receptor (GPCR) agonists
that activate phospholipase C (PLC). Activation of GPCR, includ-
ing bradykinin, 5HT2A and metabotropic glutamate receptors,
stimulates PLC activity that produces inositol 1,4,5-trisphos-
phate (InsP3), which binds to its receptor (InsP3R), an endoplas-
mic reticulum (ER)-localized Ca2+ channel, resulting in release of
Ca2+ from the ER and elevation of [Ca2+]i (Foskett et al., 2007).
Enhanced Ca2+ release could not be attributed to altered
amounts of Ca2+ in the ER or number of agonist receptors or
to plasma membrane influx pathways (Ito et al., 1994). It was
suggested that alteration of InsP3R-mediated Ca
2+ release was
a fundamental defect in AD, although the molecular mechanisms
were undefined. Subsequently, it was demonstrated that en-
hanced InsP3-mediated Ca
2+ signaling was a highly predictive
diagnostic feature of AD-derived peripheral cells (Hirashima
et al., 1996). Many subsequent studies have confirmed that mu-
tant PS expression is associated with exaggerated ER Ca2+ re-
lease in several cellular and animal model systems including cells
from FAD patients (Etcheberrigaray et al., 1998; Hirashima et al.,Neuron 58, 871–883, June 26, 2008 ª2008 Elsevier Inc. 871
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Presenilins Regulate InsP3R Channel GatingFigure 1. Effects of PS1 Expression on InsP3R Single-Channel Activity in Sf9 Cells
(A–C) Representative current recordings in isolated nuclei from Sf9 cells infected with PS1 WT or M146L baculoviruses in absence (A) or presence of saturating
(10 mM; B) or subsaturating (33 nM; C) InsP3 in pipette solution. Channel activity was not evoked by PS1 alone in absence of InsP3 (A), whereas InsP3R channels
were activated in presence of InsP3 (B and C). Pipette [Ca
2+] was 1 mM; arrows: zero current level. Summary of effects of PS1 expression on InsP3R channel open
probability Po (D) mean open time (to) (E) and mean closed time (tc) (F). Bars indicate standard error of the mean. Asterisks: p < 0.01, unpaired t test. Data pre-
sented in Table S1.1996; Ito et al., 1994), neuronal and nonneuronal cells engi-
neered to express recombinant mutant PS proteins (Cedazo-
Minguez et al., 2002; Guo et al., 1996; Johnston et al., 2006;
Leissring et al., 1999a, 1999b, 2001; Smith et al., 2002) and cells
from mutant PS transgenic animals (Leissring et al., 2000), in-
cluding brain neurons (Barrow et al., 2000; Mattson et al.,
2000; Schneider et al., 2001; Stutzmann et al., 2004, 2006)
long before the appearance of plaques and tangles (Stutzmann
et al., 2004). A ‘‘Ca2+ overload’’ hypothesis has been widely in-
voked to account for exaggerated Ca2+ release in mutant PS-ex-
pressing cells (discussed in Stutzmann, 2005), but increased ER
Ca2+ stores have not been consistently observed (Giacomello
et al., 2005; Ito et al., 1994; Lessard et al., 2005; Zatti et al.,
2004, 2006) nor is there a consensus regarding possible molec-
ular mechanisms involved (Gandy et al., 2006; LaFerla, 2002;
Smith et al., 2005a; Stutzmann, 2005). Here, we have discovered
a mechanism that can account for intrinsic altered Ca2+ signaling
in AD cells that involves a biochemical and functional interaction
of WT and FAD mutant PS with the InsP3R Ca
2+ release channel.
The biochemical interactions of FAD mutant PS1 or PS2 with the
InsP3R profoundly enhance the activity (gating) of the channel
that results in and can account for exaggerated cellular Ca2+ sig-
naling. By use of InsP3R-deficient cells, we show that this en-
hancement is directly involved in mutant PS-mediated APP pro-
cessing (Ab generation), an important feature of AD pathology
(Mattson and Guo, 1997).872 Neuron 58, 871–883, June 26, 2008 ª2008 Elsevier Inc.RESULTS
Modulation of InsP3R Channel Activity
by PS1 in Sf9 Cells
The effects of PS expression on InsP3R channel activity were ex-
amined in native ER membranes by single-channel patch-clamp
electrophysiology of the outer membrane of isolated Sf9 cell nu-
clei (Ionescu et al., 2006). Insect cells express a single InsP3R
isoform, most closely related to the mammalian type 1 channel,
the predominant brain isoform (Foskett et al., 2007), that has per-
meation and gating properties and ligand regulation very similar
to those of mammalian InsP3R channels (Ionescu et al., 2006). In
membrane patches from control nuclei, InsP3R channels ex-
posed to optimal ligand conditions (10 mM InsP3, 1 mM Ca
2+)
were consistently detected, and they gated with high open prob-
ability (Po = 0.76 ± 0.05, n = 10; Figure 1B and see Table S1 avail-
able online). Human wild-type PS1 (PS1-WT) and FAD mutant
PS1 M146L (PS1-M146L) were expressed in Sf9 cells as full-
length holoproteins (Figure S1) throughout the ER (not shown)
and in the nuclear envelope (Figure S2). In nuclei from either
FAD mutant PS1-M146L- or PS1-WT-expressing cells, no novel
ion channels were detected (n = 59; Figure 1A). Nor were channel
activities observed in the absence of InsP3 (n = 10; Figure 1A) or
in the presence of InsP3 together with its competitive inhibitor
heparin (100 mg/ml; n = 7; not shown). InsP3R channels observed
in the presence of saturating 10 mM InsP3 in membrane patches
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Presenilins Regulate InsP3R Channel Gatingfrom PS1-WT-infected cells had Po similar to those from mock-
infected or uninfected cells (p > 0.05; Figures 1B and 1D). In con-
trast, Po was elevated (p < 0.05) in PS1-M146L-infected cells
(Po = 0.86 ± 0.03; Figures 1B and 1D), with many channels ob-
served to be ‘‘locked open’’ for long periods (as in Figure 1B),
a gating behavior only extremely rarely observed in control chan-
nels (unpublished data). PS1-M146L enhanced InsP3R gating in
saturating [InsP3] by prolonging the channel open time
(Figure 1E). Interestingly, PS1-WT also enhanced the mean
open time, although to a lesser extent than mutant PS1 (Fig-
ure 1E), and it also enhanced the mean closed time (Figure 1F).
With [InsP3] lowered to 33 nM, InsP3R channel Po in patches
from control nuclei was reduced to 0.27 ± 0.01, reflecting the
[InsP3] dependence of gating (Ionescu et al., 2006). Strikingly,
Po was elevated by nearly 3-fold in patches from nuclei isolated
from the FAD mutant PS1-expressing cells (Po = 0.75 ± 0.06), to
a level that was comparable to that observed in saturating [InsP3]
(Figures 1C and 1D). Enhanced Po was caused by a marked de-
stabilization of the channel closed state (enhanced opening rate)
as well as prolongation of the open time (Figures 1E and 1F). In
contrast, PS1-WT was without effect on Po (Figure 1D); although
it appeared to influence channel gating, reflected as a small in-
crease of the channel mean closed time (Figure 1F).
Biochemical Interaction of PS1 with InsP3R
These results demonstrate a gain-of-function effect of mutant PS1
on InsP3R channel activity observed at the single-channel level.
Because the effects of FAD PS1 expression were observed in iso-
lated nuclei, we speculated that this functional effect was caused
by an association of PS with the InsP3R in the ER membrane
patches. PS1-WT and PS1-M146L immunoprecipitates from Sf9
cells that had been co-infected with rat types 1 or 3 InsP3R con-
tainedboth InsP3R channel isoforms (Figure2A). Similarly,PS1 im-
munoprecipitates from mouse whole brain lysates contained the
type 1 InsP3R (Figure 2C). These results demonstrate a biochemi-
cal interaction between InsP3R and both WT and mutant PS1.
Modulation of InsP3R Channel Activity by PS1
in DT40 Cells
Similar studies were undertaken in chicken DT40 cells, using
analogous protocols, but with polyclonal lines engineered to sta-
bly express either WT or mutant PS1 proteins (Figure S3). A DT40
line with all three InsP3R isoforms genetically deleted (InsP3R-KO
DT40) constitutes the only InsP3R null cell line available (Suga-
wara et al., 1997). We reasoned that if PS1 similarly affected gat-
ing of InsP3R channels in native InsP3R-expressing DT40 cells,
the generality of this as a molecular mechanism associated
with FAD mutant PS1 could be established, and furthermore
that use of InsP3R-KO DT40 cells would be valuable for investi-
gating the physiological relevance of the PS-InsP3R interaction.
As in the Sf9 cell recordings, no novel ion channel activities were
observed in nuclei from the wild-type or mutant PS1-expressing
native DT40 cells (not shown). Importantly, highly similar effects
of PS expression on InsP3R channel behavior were observed as
in the Sf9 cells (Figure 3; Table S2). Thus, in saturating [InsP3],
PS1-WT was without effect (Po = 0.53 ± 0.05 in control versus
0.57 ± 0.07 in PS1-WT transfected cells), whereas PS1-M146L
expression increased channel activity (Po = 0.83 ± 0.04;p < 0.01; Figures 3A and 3C) by locking the channel open for
long periods (Figure 3D). In suboptimal [InsP3] (100 nM), mutant
PS1 stimulated channel activity by 4-fold (Po = 0.63 ± 0.07 versus
0.16 ± 0.02 for control cells; Figures 3B and 3C) to levels similar
to those observed for control channels in saturating [InsP3]. Also
as in Sf9 cells, PS1-WT was without effect onPo, although it influ-
enced channel gating, as evidenced by small effects on both
mean open and closed times (Figures 3D and 3E).
Figure 2. Biochemical Interaction between PS and InsP3R
Western blot of PS1 (A) or PS2 (B) immunoprecipitates from lysates of Sf9 cells
coexpressing either PS1-WT or PS1-M146L (A) or PS2-WT or PS2-N141I (B)
with rat InsP3R isoforms 1 or 3; expressed proteins shown at top and probing
antibodies shown on right.
(C) Western blots of PS1 (top) and PS2 (bottom) immunoprecipitates from
mouse brain lysate. Top: lanes 1 and 2, total input; lane 3, IgG immunoprecip-
itate control; lane 4, PS1 immunoprecipitate. Bottom: lane 1, total input; lane 2,
PS2 immunoprecipitate; lane3, rabbit serum immunoprecipitate control.Neuron 58, 871–883, June 26, 2008 ª2008 Elsevier Inc. 873
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Presenilins Regulate InsP3R Channel GatingFigure 3. Effects of PS1 Expression on InsP3R Single-Channel Activity in DT40 Cells
Representative InsP3R single-channel current recordings in presence of saturating (10 mM; A) or subsaturating (100 nM; B) InsP3 in DT40 cells stably
transfected with PS1 WT or M146L. Pipette [Ca2+] was 1 mM, optimal for channel activity; arrows: zero current level. Summary of effects of PS1 expression on
InsP3R Po (C), mean open time (to) (D), and mean closed time (tc) (E). Bars indicate standard error of the mean. Asterisks: p < 0.01, unpaired t test. Data presented
in Table S2.The similar behaviors of InsP3R gating from different species in
different cell systems in response to expression of FAD mutant
and WT PS1 strongly suggests that this is a fundamental channel
regulatory mechanism.
Modulation of InsP3R Channel Activity by PS2
Altered [Ca2+]i signaling has been observed in cells expressing
either FAD mutant PS1 or PS2 (Gandy et al., 2006; LaFerla,
2002; Smith et al., 2005a; Stutzmann, 2005). Like PS1, wild-
type PS2 (PS2-WT) and FAD mutant PS2 N141I (PS2-N141I)
also localized to the nuclear envelope (Figure S2) and inter-
acted biochemically with the InsP3R (Figures 2B and 2C).
With 10 mM InsP3 in the pipette solution, InsP3R channels
from PS2-WT-infected cells (Figure S1) had Po similar to those
from mock-infected cells (p > 0.05; Figures 4A and 4C; Table
S3). In contrast, Po was elevated (p < 0.05) in PS2-N141I ex-
pressing cells (Po = 0.81 ± 0.02; Figure 4C). As observed for
PS1-M146L, many channels observed in PS2-N141I nuclei
were ‘‘locked open’’ (as in Figure 4A). With subsaturating
[InsP3], Po in patches from PS2-N141I nuclei was elevated by
nearly 3-fold compared with Po observed in nuclei from mock
or PS2-WT-expressing cells (Figure 4C). Similar to the effect
of PS1-M146L, elevated Po was caused primarily by marked
enhancement of the opening rate and prolongation of the
mean open time (Figures 4D and 4E). PS2-WT was without ef-
fect on channel Po (Figures 4B and 4C), but it influenced gating,
reflected as increases in the mean closed and open times (Fig-
ures 4D and 4E). These effects of WT and FAD mutant PS2 on
InsP3R gating are highly similar to those observed for WT and
mutant PS1, respectively, strongly suggesting that aberrant
modulation of InsP3R channel gating is a general property of
FAD mutant PS.874 Neuron 58, 871–883, June 26, 2008 ª2008 Elsevier Inc.Exaggerated Ca2+ Signaling in Mutant
PS1-Expressing Cells
To address whether these effects of FAD mutant PS observed at
the single-channel level account for altered [Ca2+]i signaling in
AD cells, InsP3R-mediated Ca
2+ signals were recorded in the
DT40 cell lines that were used for the single-channel studies
and that had comparable levels of InsP3R expression
(Figure S3). Physiological InsP3R-mediated Ca
2+ signals were
elicited by crosslinking the B cell receptor (BCR). A high concen-
tration of anti-IgM (5 mg/ml) triggered a rapid increase in [Ca2+]i in
control cells (Figure 5A) due to InsP3-mediated Ca
2+ release from
intracellular stores (Sugawara et al., 1997). In PS1-WT-express-
ing cells, the magnitude and kinetics were similar to those ob-
served in control cells. In contrast, exaggerated [Ca2+]i re-
sponses were observed in PS1-M146L-expressing cells
(Figure 5A), with the peak response over 1.5-fold higher than in
control or PS1-WT-expressing cells (Figure 5B). Thus, the
DT40 cell system recapitulates the exaggerated [Ca2+]i re-
sponses observed in peripheral cells from FAD patients and neu-
ronal and nonneuronal animal and model cells expressing FAD
mutant PS. In response to a low anti-IgM concentration (0.05
mg/ml) expected to generate less InsP3, repetitive [Ca
2+]i oscilla-
tions were triggered in 52% ± 5% of control cells (Figures 5C and
5D), due to periodic Ca2+ release through the InsP3R (White et al.,
2005) after a long lag period (Figure 5F) as [InsP3] increased to
levels sufficient for channel stimulation. In cells expressing
PS1-M146L, the peak amplitude of the oscillations was similar
to those observed in control and PS1-WT-expressing cells
(Figure S4), whereas both the oscillation frequency and number
of responding cells were increased, and the latency between ap-
plication of agonist and the first [Ca2+]i response was decreased
(Figures 5C–5F). Of note, the latency was nearly abolished in
Neuron
Presenilins Regulate InsP3R Channel GatingFigure 4. Effect of PS2 on InsP3R Single-Channel Activity in Sf9 Cells
(A and B) Representative current recordings in isolated nuclei from Sf9 cells infected with PS2 WT or N141I baculovirus in the presence of saturating (10 mM; A) or
subsaturating (33 nM; B) InsP3. Pipette [Ca
2+] was 1 mM; arrows: zero current level. Summary of effects of PS2 expression on InsP3R Po (C), channel mean open
time (to) (D), and channel mean closed time (tc) (E). Bars indicate standard error of the mean. Asterisks: p < 0.01, unpaired t test. Data presented in Table S3.a significant subset (30%) of cells expressing PS1-M146L (Fig-
ures 5C and 5F). This response is highly reminiscent of that of
control cells to saturating concentrations of BCR antibody
(Figure 5A) and was never observed in control or PS1-WT-ex-
pressing cells. Increased number of oscillating cells, enhanced
oscillation frequency and diminished latencies are all consistent
with a heightened InsP3 sensitivity of InsP3R-mediated Ca
2+ re-
lease in the FAD mutant PS1-expressing cells. Interestingly, the
number of responding cells was increased and the latency was
shortened in the PS1-WT-expressing cells (Figures 5D and 5E),
although to a lesser extent than the more exaggerated re-
sponses observed in cells expressing FAD mutant PS1.
Spontaneous InsP3R-dependent [Ca
2+]i oscillations were ob-
served in 6% of control cells perfused with Hank’s balanced
salt solution without stimulation (Figures 5G and 5H), as
observed previously (White et al., 2005). Expression of PS1-WT
approximately doubled the percentage of cells displaying this
behavior (Figure 5H). In contrast, a 4-fold higher percentage,
25%, of the PS1-M146L-expressing cells exhibited spontane-
ous [Ca2+]i oscillations (Figure 5H). Furthermore, the oscillation
frequency in these cells was also enhanced (Figure 5I). In a sub-
set of the mutant PS1-expressing cells (4%), spontaneous ex-
aggerated [Ca2+]i transients were observed that were never seen
in control and PS1-WT-expressing cells (Figure 5G).
These results are congruent with those obtained in the single-
channel studies. In both sets of experiments, exaggerated re-
sponses to InsP3, particularly under conditions of low [InsP3],
were observed in the context of FAD mutant PS1 expression,
with PS1-WT expression also having effects, but much less ex-aggerated. The congruence of two very different sets of data
suggests that the observed exaggerated [Ca2+]i responses are
due to the observed exaggerated InsP3R single-channel re-
sponses.
Exaggerated Ca2+ Signaling in Mutant PS1-Expressing
Cells is Due to Altered InsP3R Gating
Exaggerated [Ca2+]i responses have been a consistent observa-
tion in cells expressing mutant PS proteins (LaFerla, 2002; Smith
et al., 2005a; Stutzmann, 2005; Yoo et al., 2000), but it has been
suggested that they are caused by enhanced expression of re-
lease channels (Chan et al., 2000; Kasri et al., 2006; Schneider
et al., 2001; Smith et al., 2005b; Stutzmann et al., 2006) or over-
filling of ER Ca2+ stores (Leissring et al., 2000; Leissring et al.,
2001; Schneider et al., 2001; Tu et al., 2006). We therefore exam-
ined whether either factor contributed to the exaggerated [Ca2+]i
responses observed here in DT40 cells. All three cell lines ex-
pressed approximately equal levels of the types 1 and 3 InsP3R
(Figure S3). Thus, the exaggerated responses cannot be
accounted for by altered InsP3R expression in our studies. To in-
vestigate the filling state of intracellular Ca2+ stores, we evalu-
ated [Ca2+]i responses to the Ca
2+ ionophore ionomycin or the
SERCA inhibitor thapsigargin applied in the absence of extracel-
lular Ca2+ so that the observed [Ca2+]i responses were due
entirely to Ca2+ derived from intracellular compartments.
Ionomycin (5 mM) triggered a rapid release of Ca2+ that was
diminished in the PS1-M146L- but not PS1-WT-expressing
cells (Figure S5). Similarly, Ca2+ released in response to thapsi-
gargin (1 mM) was also significantly reduced in the mutantNeuron 58, 871–883, June 26, 2008 ª2008 Elsevier Inc. 875
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Presenilins Regulate InsP3R Channel GatingFigure 5. Exaggerated [Ca2+]i Signaling in Mutant PS-Expressing
DT40 Cells
(A and B) Responses to strong stimulation by BCR antibody of DT40 cell
[Ca2+]i. (A) Representative single-cell responses to 5 mg/ml anti-IgM (added
at arrow) in untransfected (blue) and PS1-WT (red) and PS1-M146L (green)
stably-transfected DT40 cells. (B) Summary of peak [Ca2+]i responses trig-
gered by 5 mg/ml anti-IgM (n = 90). Asterisk: p < 0.01 compared with WT and
PS1-WT.
(C–F) Responses to weak stimulation by BCR antibody of DT40 cell [Ca2+]i. (C)
Representative single cell [Ca2+]i responses to 50 ng/ml anti-IgM (IgM; added at
arrow) stimulation of BCR in control (blue), PS1-WT (red) and PS1-M146L
(green and pink) stably transfected DT40 cells. (D) Summary of percentage of
cells responding to 50 ng/ml anti-IgM (n = 90). Approximately thirty percent
(purple) of PS1-M146L-expressing cells exhibited a different, exaggerated876 Neuron 58, 871–883, June 26, 2008 ª2008 Elsevier Inc.PS1-expressing cells and, to a lesser extent, in the PS1-WT-ex-
pressing cells (Figure S5). These results suggest that the Ca2+
stores are not overloaded in mutant PS1-expressing cells and
may in fact even be reduced. To examine the filling state of the
ER Ca2+ stores more directly, ER [Ca2+] was measured with
the low-affinity fluorescence indicator Mag-Fura-2 (Laude
et al., 2005). Addition of MgATP to a solution bathing permeabi-
lized cells with Ca2+ stores depleted (not shown) enhanced the
fluorescence ratio as a consequence of SERCA-mediated load-
ing of intracellular stores with Ca2+ (Figure 6). At steady state, the
stores in the FAD PS1-expressing cells were loaded less fully than
in control or PS1-WT-expressing cells (Figure 6A; p < 0.01), con-
firming that the Ca2+ stores are not overloaded in the mutant
PS1-expressing cells. In contrast, when loading was performed
in the presence of the InsP3R inhibitor heparin, the steady-state
level of ER Ca2+ was similar in all the cell lines (Figure 6B). Thus,
the exaggerated [Ca2+]i responses observed in mutant PS1-ex-
pressing DT40 cells (Figure 5) cannot be accounted for by over-
filling of ER Ca2+ stores. Rather, a reduced ER Ca2+ was observed
in the FAD-PS1 expressing cells that appeared to be due an ac-
tivated heparin-sensitive Ca2+ leak through the InsP3R. This was
more directly examined by use of a different protocol, in which the
Ca2+ leak permeability of the ER membrane was measured fol-
lowing the addition of thapsigargin to cells with ER stores filled
with Ca2+ to equivalent levels. The Ca2+ leak rate was similar in
control and PS1-WT cells, whereas it was greater in the FAD mu-
tant PS1-expressing cells (Figures 6C and 6D). This enhanced
Ca2+ leak observed in the PS1-M146L cells was eliminated by
addition of heparin (Figures 6E and 6F), suggesting that it was
mediated by the InsP3R. To test this rigorously, we generated
stable PS1-expressing DT40 cells with genetic disruption of all
three InsP3R genes (Sugawara et al., 1997). In the absence of
InsP3R expression (Figure S3), both anti-IgM-induced and spon-
taneous [Ca2+]i signals were absent (not shown). Notably, the
sizes of the intracellular Ca2+ stores in the PS1-M146L- or
PS1-WT-expressing cells were similar in the InsP3R-deficient
cells (Figure 6G). Importantly, the enhanced PS1-M146L induced
ER Ca2+ leak rate was absent in the InsP3R-deficient cells
(Figure 6H). These results demonstrate that exaggerated Ca2+
signaling, reduced Ca2+ store size, and enhanced ER Ca2+ leak
permeability are specific properties of PS1-M146L-expressing
cells and, furthermore, that these features are completely
dependent on the InsP3R. Together, these results strongly
[Ca2+]i response. (E) [Ca
2+]i oscillation frequency triggered by anti-IgM in WT
DT40, PS1-WT-expressing, and PS1-M146L-expressing cells. (F) Summary
of latencies to first response in WT DT40, PS1-WT-expressing, and PS1-
M146L-expressing cells. The 30% of PS1-M146L-expressing cells that ex-
hibited the exaggerated response had nearly no latency (purple).
(G–I) Spontaneous [Ca2+]i oscillations in PS1-expressing DT40 cells. (G) Repre-
sentative spontaneous single-cell [Ca2+]i oscillations in control (blue) and PS1-
WT (red) and PS1-M146L (green and purple) stably transfected DT40 cells.
Some PS1-M146L-expressing cells (4%, purple) displayed a distinct, exag-
gerated spontaneous [Ca2+]i signal (bottom). (H) Percentage of cells displaying
spontaneous [Ca2+]i oscillations (n = 90). (I) Spontaneous [Ca
2+]i oscillation fre-
quency observed in WT DT40 cells and PS1-WT- and PS1-M146L-expressing
DT40 cells.
Asterisks: p < 0.01 compared with WT DT40 cells. Asterisks with bars: p < 0.01
PS1-WT versus PS1-M146L. Bars indicate standard error of the mean.
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Presenilins Regulate InsP3R Channel Gatingsuggest that mutant PS1-M146L diminishes the size of the ER
Ca2+ store by a mechanism that involves its enhancement of
InsP3R channel activity, a process that disrupts the normal
Ca2+ pump/leak balance in favor of enhanced leak mediated by
InsP3-dependent InsP3R-mediated Ca
2+ permeability. We con-
clude, therefore, that the observed altered InsP3R single-channel
activity most likely accounts for the altered [Ca2+]i signals
observed.
FAD Mutant PS1 Enhances InsP3R-Mediated
ER Ca2+ Permeability in Brain Neurons
Whereas FAD mutant PS associated exaggerated Ca2+ signaling
has been observed in many cell types, AD pathophysiology is
Figure 6. The Amount of Ca2+ in the ER
Store Is Not Increased by PS1-M146L Ex-
pression, Due to FAD Mutant PS1- and
InsP3R-Dependent Enhanced Ca
2+ Leak
Permeability of the ER Membrane
(A) ER [Ca2+] expressed as Mag-Fura-2 ratio nor-
malized to ratio at t = 0 before and then during fill-
ing upon addition of MgATP (1.5 mM) and subse-
quent emptying by addition of InsP3 (10 mM) in
control (blue) and PS1-WT (red) and PS1-M146L
(green) stable DT40 cells. Insert: Steady-state ER
[Ca2+] in presence of MgATP. Asterisks: p < 0.01
compared with control cells. Cross: p < 0.01 com-
pared with PS1-WT.
(B) Similar experiment with ER Ca2+ loading per-
formed in presence of heparin (100 mg/ml). Aster-
isk: p < 0.01 and < 0.05 compared with control
and PS1-WT cells, respectively.
(C) ER [Ca2+] during filling upon addition of MgATP
(1.5 mM) in presence of heparin (100 mg/ml) and
then after removal of MgATP and addition of thap-
sigargin (1 mM), in control (blue), and PS1-WT (red)
and PS1-M146L (green) stable DT40 cells.
(D) Summary of ER Ca2+ leak rate, calculated as ini-
tial rate of decline of the Mag-Fura-2 ratio. Asterisk:
enhanced leak observed in M146L-expressing
cells compared with control and PS1-WT (p < 0.01).
(E) Similar experiments as in (D), except that hep-
arin (100 mg/ml) was present during measure-
ments of the Ca2+ leak rate.
(F) Summary of ER Ca2+ leak rate in presence of
heparin.
(G) Similar experiment as in (D) performed in cells
lacking InsP3R expression (KO). Insert: steady-
state ER [Ca2+] after MgATP-induced loading.
(H) Summary of ER Ca2+ leak rate in PS1 express-
ing InsP3R KO cells.
Bars indicate standard error of the mean.
manifested primarily in brain neurons.
To determine if FAD PS1 expression
was associated with altered InsP3R-me-
diated Ca2+ release in brain neurons, cor-
tical neurons were isolated from E15–E16
mouse brains, and the Ca2+ permeability
properties of the ER membranes were
measured as above (Figure 7A). The
steady-state level of Ca2+ accumulated
in the ER lumen was not different between control cells and neu-
rons expressing either WT or M146L-PS1 (Figure 7B). The Ca2+
leak permeability measured upon addition of thapsigargin was
somewhat higher in PS1-M146L expressing neurons than in
those expressing PS1-WT (p < 0.05), although it was not different
compared with control cells (Figure 7C). In a separate set of ex-
periments (Figure 7D), 33 nM InsP3 failed to elicit Ca
2+ release in
control or PS1-WT cells, whereas it simulated Ca2+ release from
the ER of PS1-M146L cells (Figure 7E), with an initial rate that
was comparable to that achieved by addition of saturating
(10 mM) InsP3 to the control cells (Figure 7F). Thus, as in the non-
neuronal cells examined, FAD mutant PS1 specifically sensitizes
InsP3R-mediated Ca
2+ release in brain cortical neurons.Neuron 58, 871–883, June 26, 2008 ª2008 Elsevier Inc. 877
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Presenilins Regulate InsP3R Channel GatingFigure 7. FAD Mutant PS1 Enhances InsP3R-Mediated ER Ca
2+ Permeability in Brain Neurons
(A) ER [Ca2+], expressed as Mag-Fura-2 ratio normalized to ratio at t = 0, before and then during filling upon addition of MgATP (1.5 mM), and subsequent ex-
posure to 1 mM thapsigargin in control (blue) and PS1-WT (red)- and PS1-M146L (green)-transfected mouse cortical neurons.
(B) Summary of steady-state ER [Ca2+] following MgATP-induced loading in (A).
(C) Summary of Ca2+ leak rate measured in presence of thapsigargin in (A). Asterisk: p = 0.01.
(D) ER [Ca2+] during filling upon addition of MgATP (1.5 mM) in control (black) and EGFP (blue)-, PS1-WT (red)-, and PS1-M146L (green)-transfected mouse cor-
tical neurons.
(E) Response of ER [Ca2+] to 33 nM InsP3 in cells from (D) and in control cells in response to 10 mM InsP3 (black trace).
(F) Summary of initial Ca2+ release rate, expressed as Mag-Fura-2 ratio, from (E).
Asterisks: p < 0.01 compared with control and PS1-WT. Bars indicate standard error of the mean.Functional Consequences of InsP3R-PS1
Interaction—APP Processing
Identification of a molecular mechanism that links FAD mutant PS
to altered [Ca2+]i signaling provides an opportunity for insights
into relationships between pathological features of AD and al-
tered [Ca2+]i signaling. PS1 is the core subunit of the g-secretase
that enzymatically cleaves APP into amyloid peptides, including
Ab40 and Ab42 (Edbauer et al., 2003). FAD PS mutations alter sec-
retase function by either modifying its sequence specificity or ab-
solute activity, such that the relative proportion or amount of Ab42
produced is increased (Citron et al., 1997; Scheuner et al., 1996).
To determine the relevance of the functional interaction of PS1
and InsP3R for APP processing, we engineered DT40 cells to sta-
bly express APP harboring Swedish mutations (APPSWE) that en-
hance production of Ab species (Scheuner et al., 1996), together
with either PS1-WT or PS1-M146L (Figure 8A). PS1-M146L spe-
cifically enhanced Ab40 and Ab42 by 2- and 3-fold, respec-
tively, compared with control cells. This result is consistent with
observations in other cell types (Citron et al., 1997), validating
again the use of this model system. Of note, the Ab42/Ab40 ratio
was enhanced in the FAD mutant PS1-expressing cells (Figure 8),
as observed in AD patients. To determine the role of the InsP3R in
PS1-dependent APP processing, APP and PS1-expxressing
cells were generated in the InsP3R-KO background, and APP
processing was similarly evaluated. Remarkably, the mutant
PS1 enhancement of Ab secretion observed in the InsP3R-ex-
pressing cells was abolished. Furthermore, the absolute levels
of Ab peptides detected were strongly reduced in all control
and PS1-expressing InsP3R-KO lines (Figure 8B). These results878 Neuron 58, 871–883, June 26, 2008 ª2008 Elsevier Inc.indicate that altered APP processing by mutant PS1-M146L
PS1 has a strong dependence on the InsP3R.
DISCUSSION
The underlying pathogenic mechanisms of Alzheimer’s disease
remain obscure. In this study, we considered that dysregulated
[Ca2+]i signaling is a proximal mechanism in AD. We used non-
neuronal model cell systems because they provided unique ad-
vantages for deciphering the molecular mechanisms involved
and confirmed the major results in primary brain neurons. Both
the InsP3R (Foskett et al., 2007) as well as presenilins (Hebert
et al., 2004) are widely distributed throughout all tissues investi-
gated, with the highest levels of PS expression outside the brain
(Hebert et al., 2004), and similar Ca2+ signaling abnormalities
have been observed in several peripheral and neuronal cell types
that express mutant PS (LaFerla, 2002; Smith et al., 2005a;
Stutzmann, 2005). We have demonstrated that FAD mutant pre-
senilins interact biochemically and functionally with the InsP3R
Ca2+ release channel and exert profound stimulatory effects on
its gating activity that result in exaggerated Ca2+ signaling in in-
tact cells, including brain neurons. Our results indicate that this
functional interaction has physiological implications that may
be relevant in AD, including APP processing.
Presenilins Regulate InsP3R Ca
2+ Release
Channel Gating
We observed that expression of two FAD mutant PS (PS1-
M146L and PS2-N141I) each had strong and similar effects on
Neuron
Presenilins Regulate InsP3R Channel Gatingthe gating of single InsP3R Ca
2+ release channels. We attempted
to ensure equal levels of expression of InsP3R and the different
PS proteins among the different groups of cells, but this could
not be achieved perfectly. Nevertheless, because very similar re-
sults were obtained in two very distinct cell systems, Sf9 and
DT40 cells, this was likely not a significant confounding variable.
In both systems, mutant PS expression caused the InsP3R chan-
nel to gate as actively in low submaximal [InsP3] as it normally
does in saturating [InsP3]. Elevated Po in low [InsP3] by FAD mu-
tant PS was caused primarily by a substantial increase of chan-
nel opening rate, the major mechanism whereby InsP3 activates
the channel (Foskett et al., 2007), indicating that mutant PS
enhances InsP3R gating by sensitizing it to low [InsP3]. This
Figure 8. APP Processing Is Dependent on InsP3R
(A) Stable expression of PS1-WT and PS1-M146L proteins in wild-type (WT)
and InsP3R-deficient (KO) DT40 cell lines that stably expressed APPSWE. Actin
probed as loading control.
(B) ELISA measurements of Ab40 (top), Ab42 (middle), and Ab42/Ab40 ratio (bot-
tom) secreted over 48 hr by InsP3R-expressing wild-type (WT; left) or InsP3R-
deficient (KO DT40 cells; right) DT40 cells stably expressing APPSWE alone
(blue) or APPSWE with PS1-WT (red) or PS1-M146L (green).
Bars indicate standard error of the mean. Asterisks: p < 0.01 compared with
control WT cells. Cross: p < 0.01 compared with control WT cells; double
cross: p < 0.01 compared with PS1-WT cells.mechanism is likely an allosteric one mediated by interaction of
PS with the InsP3R that is preserved in isolated nuclei. Both
membrane proteins localized to the nuclear envelope and mu-
tant- as well as WT-PS coimmunoprecipitated to the same ex-
tent with mammalian InsP3R, suggesting that PS mutations do
not strongly affect the biochemical interaction. Although WT
PS1 or PS2 did not affect channel Po, small effects on InsP3R
channel gating were nevertheless observed. It has been debated
whether FAD PS mutations are gain or loss of function (Shen and
Kelleher, 2007). Here, we show an apparent gain in InsP3R func-
tion by FAD mutant PS expression. However, channel dwell time
analyses suggest that WT PS1 and PS2 also influence InsP3R
channel gating. It is possible therefore that the gain-of-function
phenotype we observe is due to disruption by mutant PS of nor-
mal PS-WT regulation of InsP3R channel activity. Future studies
of the InsP3R gating behaviors in PS-deficient cells will be infor-
mative in this regard.
FAD Mutant PS1-Mediated Enhanced InsP3R Gating
Causes Exaggerated [Ca2+]i Signaling
Analysis of our single-channel data suggests that mutant PS1
and PS2 stimulate InsP3R gating by sensitizing the channel to
InsP3. One of the most consistent observations of the effects
of FAD PS on Ca2+ signaling is potentiation of InsP3-mediated
Ca2+ release (Smith et al., 2005a; Yoo et al., 2000). Nevertheless,
the molecular mechanisms have remained obscure. InsP3-medi-
ated [Ca2+]i signals in FAD patient fibroblasts were exaggerated
in response to low agonist concentrations (Ito et al., 1994), con-
sistent with an enhanced sensitivity to InsP3 in AD. The magni-
tude and rate of [Ca2+]i rise in response to photo-release of
InsP3 were enhanced by FAD mutant PS in Xenopus oocytes
(Leissring et al., 1999a, 1999b). Furthermore, Ca2+ puffs, low-
level Ca2+ release events mediated by clusters of InsP3R in re-
sponse to submaximal [InsP3], were both more frequent and
likely to generate [Ca2+]i waves in the FAD mutant PS-expressing
cells (Leissring et al., 2001). In brain slices from PS1-M146V
knockin mice, photo-release of InsP3 caused 3-fold greater
Ca2+ release than in nontransgenic neurons and enhanced the
number of neurons responding and those exhibiting strong re-
sponses (Stutzmann et al., 2004). By demonstrating that mutant
PS sensitizes the InsP3R to InsP3, our new results provide a mo-
lecular mechanism that is consistent with these previous obser-
vations and can therefore possibly account for them. To test this
idea, the relevance of the observed effects of FAD PS1 expres-
sion on InsP3R single-channel gating was determined by mea-
suring [Ca2+]i responses in PS-expressing DT40 cells, the
same cells used for the single-channel studies, that had compa-
rable levels of InsP3R expression. Exaggerated Ca
2+ release re-
sponses to both high- as well as low-threshold concentrations of
agonist were observed in the cells that expressed the PS1-
M146L protein. In a significant proportion of the FAD mutant
PS-expressing cells, the [Ca2+]i responses to low agonist con-
centrations mimicked the responses of normal cells to a saturat-
ing agonist concentration. Furthermore, a high percentage of
PS1-M146L-expressing unstimulated cells displayed spontane-
ous low-level [Ca2+]i signals in the absence of agonist stimula-
tion. Most importantly, the exaggerated Ca2+ responses were
mediated specifically by the InsP3R, since they were absent inNeuron 58, 871–883, June 26, 2008 ª2008 Elsevier Inc. 879
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enhanced InsP3 sensitivity of the InsP3R in intact cells express-
ing FAD mutant PS, even to [InsP3] that may exist in resting, un-
stimulated cells. The conclusions based on the effects of PS1-
M146L expression on [Ca2+]i signals are therefore in strong
agreement with those reached from the single-channel studies.
Thus, these results suggest that exaggerated [Ca2+]i signals in
cells can be accounted for by exaggerated InsP3R gating as a re-
sult of its interaction with FAD mutant PS. Importantly, these in-
sights appear to be relevant for brain neurons, since InsP3R-me-
diated ER Ca2+ permeability was enhanced by FAD mutant PS1
expression in mouse brain cortical neurons, enabling Ca2+ re-
lease to be triggered by low [InsP3] that were without effect in
either control cells or cells expressing WT PS1.
It has been suggested that exaggerated Ca2+ release in AD
cells is due to increased filling of ER Ca2+ stores (discussed in
LaFerla, 2002; Mattson and Chan, 2003; Stutzmann, 2005).
Although this ‘‘Ca2+ overload’’ hypothesis has been widely in-
voked, many studies, including ours here, have observed either
no alteration or reduced ER Ca2+ stores in FAD PS-expressing
cells (Giacomello et al., 2005; Lessard et al., 2005; Zatti et al.,
2004, 2006). The absence of elevated ER [Ca2+] suggests that
the effects of FAD PS on InsP3R gating observed here cannot
be accounted for by possible effects of elevated luminal [Ca2+]
on channel function. Furthermore, we have observed in excised
luminal side-out nuclear patches that InsP3R channel gating is
insensitive to bath (luminal) [Ca2+] between 100 nM and 500 mM
(data not shown). Ca2+ release is affected by many variables,
including activities and expression of release channels, amount
of ER Ca2+, Ca2+ buffering, and more. Enhanced spontaneous
Ca2+ release activity observed in our PS1-M146L-expressing
DT40 cells reduced ER Ca2+, but [Ca2+]i responses to agonists
were nevertheless enhanced because of the strong effect of mu-
tant PS on InsP3R gating. Thus, exaggerated Ca
2+ release re-
sponses cannot provide unambiguous measurements of the
amount of Ca2+ in stores. Our results demonstrate that effects
of FAD mutant PS1 on both [Ca2+]i signaling and ER Ca
2+ content
are InsP3R dependent, with mutant PS1- and PS2-stimulated
InsP3R channels remaining regulated by InsP3. Thus, cell type-
specific differences in concentrations of InsP3R ligands and ex-
pression levels can contribute to the magnitude of the effect of
mutant PS1 expression on ER Ca2+, which might reconcile dis-
crepant published observations. The enhanced Ca2+ release re-
sponses observed in PS1-M146L-expressing DT40 cells are
highly reminiscent of those in peripheral and neuronal mutant
PS-expressing cells in many previous studies. The absence of
these responses in InsP3R-knockout cells, together with the
identification of a molecular mechanism observed at the single
channel level, strongly suggest that mutant PS-mediated en-
hancement of InsP3 sensitivity of the InsP3R is a fundamental un-
derlying mechanism that accounts for many observations of dys-
regulated Ca2+ signaling in AD cells and model cell systems.
It has been reported that exaggerated Ca2+ responses in cells
expressing FAD mutant PS are associated with enhanced ex-
pression or activities of ryanodine receptor (RyR) Ca2+ release
channels (Chan et al., 2000; Smith et al., 2005b; Stutzmann
et al., 2006). In AD-transgenic mouse cortical neurons, exagger-
ated responses to InsP3 were mediated in part by RyR activated880 Neuron 58, 871–883, June 26, 2008 ª2008 Elsevier Inc.by Ca2+ released through InsP3R (Stutzmann et al., 2006), sug-
gesting that exaggerated RyR responses could be a secondary
effect. Because Ca2+ signaling can influence InsP3R (Cai et al.,
2004; Genazzani et al., 1999) and RyR (P. Nicotera, personal
communication) expression, it is possible that mutant PS-
mediated enhanced InsP3R Ca
2+ signaling drives transcriptional
programs, with RyR expression upregulated as a result. Con-
versely, Ab exposure increased RyR expression in mouse corti-
cal neurons (Supnet et al., 2006), suggesting that changes in
RyR expression may be more downstream compared with
a more proximal InsP3R-mediated process described here. Al-
ternately, PS and RyR may functionally interact similar to the
PS-InsP3R interaction. PS2 has been reported to interact with
RyR2, the cardiac isoform, and PS2 knockout results in cardiac
Ca2+ signaling abnormalities (Takeda et al., 2005). In addition,
WT and mutant PS1 have been reported to interact with RyR3
(Chan et al., 2000).
It was proposed that reconstituted PS proteins form divalent
cation-permeable ion channels in bilayer membranes and that
loss of this function in FAD PS enhanced ER Ca2+, resulting in ex-
aggerated Ca2+ release responses (Nelson et al., 2007; Tu et al.,
2006). In contrast, we did not detect in native ER membranes
a cation permeability associated with either WT or FAD mutant
PS expression. Furthermore, we found that FAD mutant PS ex-
pression either reduced (DT40 cells) or had no effect (cortical
neurons) on the amount of Ca2+ in the ER. Thus, our experiments
failed to discover evidence in support of the hypothesis that PS
form ion channels.
Finally, it should be emphasized that the Ca2+ signaling abnor-
malities we observed represent proximal mechanisms distinct
from effects of Ab on Ca2+ signaling (Mattson and Guo, 1997).
Our studies indicate the presence of a complex involving PS
and InsP3R that results in hyperactivation of the Ca
2+ release
channel in a process that is independent of Ab.
Enhanced PS-Dependent InsP3R-Mediated Ca
2+
Signaling Enhances Ab Processing
Disrupted Ca2+ signaling in AD cells has been well documented,
but its physiological implications and the roles that these
changes play in AD pathogenesis have not been well studied. Al-
tered Ca2+ signaling could impinge on synaptic plasticity, mem-
brane excitability, oxidative stress, and APP processing. Identi-
fication of the InsP3R as a molecular mechanism of Ca
2+
disruption associated with FAD PS now suggests specific hy-
potheses that can be tested to evaluate the relevance of altered
Ca2+ signaling through this pathway on disease-associated
processes.
Our data suggest that one function of PS proteins may be to
regulate the activity of the InsP3R. Is there a relationship between
this activity and the activity of PS as secretases? APP process-
ing can be enhanced by elevations of [Ca2+]i (Buxbaum et al.,
1994; Jolly-Tornetta et al., 1998; Querfurth and Selkoe, 1994)
and diminished by inhibition of ER Ca2+ release (Buxbaum
et al., 1994). APP processing was examined in DT40 cells lines
engineered to stably express PS1 and APPSWE, exploiting
DT40 KO cells as the only cell type available that completely
lacks InsP3R expression. Expression of PS1-M146L caused
a nearly 3-fold increase in Ab42 compared with control and
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2-fold, recapitulating an important feature of AD (Haass and
Selkoe, 2007). Importantly, APP processing appeared to be
strongly dependent on the InsP3R, since production of Ab40
and Ab42 were substantially lower in InsP3R-deficient lines. Fur-
thermore, the PS1-M146L enhancement of Ab42 and Ab42/Ab40
were eliminated in the InsP3R-KO cells. These results suggest
that the g-secretase activity of WT and FAD mutant PS may be
regulated by either Ca2+ released through the InsP3R, or their
biochemical interaction with the channel. Our studies suggest
that InsP3R activity affects APP processing, but pharmacological
inhibition of g-secretase is without effect on InsP3R-mediated
Ca2+ signaling (Oh and Turner, 2006). Thus, the g-secretase
activity of PS is likely not involved in this mechanism by which
mutant PS regulates InsP3R channel gating.
The dependence of Ab production on InsP3R expression ob-
served here suggests that mutant PS-mediated exaggerated
Ca2+ signaling could be a proximal mechanism in AD. Brain Ab
production is driven by neuronal activity (Cirrito et al., 2005; Ka-
menetz et al., 2003), suggesting that activity and metabolic pat-
terns may contribute to Ab production and amyloid deposition
(Buckner et al., 2005). As-yet-unspecified activity- or metabo-
lism-dependent mechanisms may cause preferential accumula-
tion of amyloid that, over many years, may participate in AD pa-
thology (Buckner et al., 2005). Because of a central role of Ca2+ in
regulating both neuronal excitability (Verkhratsky, 2005) and cell
metabolism (Balaban, 2002; McCormack et al., 1990), active
brain regions are likely sites of higher Ca2+ signaling activity. Mu-
tant PS-mediated exaggerated Ca2+ release activity of the
InsP3R may therefore provide a mechanism for preferential
accumulation of amyloid. Other mechanisms that do not involve
either PS or InsP3R, but that similarly cause chronic low-level ex-
aggerated Ca2+ signaling might also be expected to result in AD
pathology. Although speculative, such mechanisms could possi-
bly be involved in sporadic forms of AD.
In summary, our results indicate that PS interact with the
InsP3R Ca
2+ release channel and modulate its gating activity.
FAD mutant PS1 and PS2 exert stimulatory effects on InsP3R
channel activity that result in perturbed cellular Ca2+ signaling.
These data provide molecular insights into the mechanisms of
enhanced InsP3-mediated Ca
2+ signals observed in cells that ex-
press FAD mutant presenilins, including those from AD patients.
Enhanced Ca2+ release from the ER as a result of this interaction
has physiological implications that may be relevant in AD, includ-
ing enhanced APP processing. These observations may provide
unique molecular insights into the ‘‘Ca2+ dysregulation hypothe-
sis’’ of AD pathogenesis and suggest novel targets for therapeu-
tic intervention.
EXPERIMENTAL PROCEDURES
Recombinant Baculovirus Constructs and Sf9 Cell Infection
Spodoptera frugiperda cells (Sf9, BD Biosciences) were maintained as de-
scribed (Ionescu et al., 2006). Human PS baculovirus constructs (PS1-WT,
PS1-M146L, PS2-WT, and PS2-N141I) were subcloned into pFastBac1; bacu-
loviruses were generated using the Bac-to-Bac system (Invitrogen). Expres-
sion was confirmed by western blotting with anti-PS1 (monoclonal
MAB5232, polyclonal MAB1563, Chemicon International, Inc.) and -PS2
(EMD Chemicals Inc.) antibodies. Localization of PS in Sf9 cells was confirmedby immunocytochemistry with anti-PS1 or -PS2 antibodies. Sf9 nuclei were
counterstained with TOTO-3 nuclear dye (Molecular Probes).
Cell Culture and Transfection
DT40 cells were maintained as described (White et al., 2005). Human wild-type
(WT) PS1 and M146L cDNAs were subcloned into pIRES2-EGFP (Clontech).
Cells were transfected using a Nucleofector Device (Amaxa). To select stable
polyclonal lines, transfected cells were cultured for 2 weeks in 2 mg ml1 Ge-
neticin (Invitrogen). PS expression was confirmed by western blot. Human APP
harboring Swedish mutations (APPSWE) was introduced into PS1-expressing
DT 40 lines by retrovirus infection. APPSWE cDNA was subcloned into
pDMX-IRES-dsRED retrovirus vector. APPSWE retrovirus was generated using
Retro-X system (Clontech). Expression of APPSWE was confirmed by western
blotting using a polyclonal anti-APP antibody. Primary cortical neurons were
prepared from embryonic day 15 (E15–16) C57BL/6J mice, as described (Me-
berg and Miller, 2003). Transfections were performed on 7- to 14-day-old cul-
tures with pIRES2-EGFP-PS1WT, pIRES2-EGFP-M146L, or pIRES2-EGFP
empty vector by n-Fect reagent (Neuromics). Experiments performed 48 hr
after transfection.
Electrophysiology
Preparation of isolated nuclei from Sf9 or DT40 cells was as described (White
et al., 2005). Nuclei were studied in standard bath solution: 140 mM KCl,
10 mM HEPES, and 0.5 mM BAPTA (free [Ca2+] = 300 nM) (pH 7.3). The pipette
solution contained 140 mM KCl, 0.5 mM ATP, 10 mM HEPES, 1 mM free
Ca2+ (pH 7.3). Free [Ca2+] in all solutions was adjusted, as described (Mak
et al., 1998). Data were acquired at room temperature and analyzed as
described (Ionescu et al., 2006).
Single-Cell Ca2+ Imaging
[Ca2+]i was measured in Fura-2-loaded DT40 cells as described (White et al.,
2005). ER Ca2+ content was estimated from changes in [Ca2+]i in response
to thapsigargin or ionomycin, as described (White et al., 2005), or with the
low-affinity Ca2+ indicator Mag-Fura-2 (Invitrogen) following procedures simi-
lar to those described in Laude et al. (2005) modified for single-cell imaging.
Following loading of cells on coverslips with Mag-Fura-2 (10 mM for 60 min),
the plasma membranes were permeabilized by exposure to 10 mg/ml digitonin
for 2 min in a medium that contained 220 nM Ca2+ and lacked MgATP. Follow-
ing 30 min of continuous perfusion with the MgATP-free bath to wash out the
digitonin, cells were alternately illuminated with 340/380 nm light and fluores-
cence intensity at 510 nm was collected with a Perkin Elmer Ultraview imaging
system. Changes in [Ca2+]ER are presented as changes in fluorescence ratio
(R/R0). R0 was verified to reflect the ratio for Ca
2+ depleted stores by using ion-
omycin (1 mM), as described (Laude et al., 2005). Ca2+ leak rates expressed as
D(R/R0) s
1.
Amyloid Beta (Ab40 and Ab42) Determinations
Ab levels in culture media were measured by sandwich ELISA (Suzuki et al.,
1994). Briefly, plates were coated with Ab N-terminal antibody Ban50 prior
to application of cell media. The concentration of Ab was determined using
horseradish peroxidase (HRP)-conjugated BA27 or BC05 antibodies to detect
Ab40 or Ab42, respectively. Ab40 or Ab42 levels were normalized to total protein
concentration. Standard curves, constructed from serial dilutions of synthetic
Ab40 or Ab42, were generated in each experiment.
Analysis and Statistics
Data were summarized as the mean ± SEM, and statistical significance of dif-
ferences between means was assessed using unpaired t tests or analysis of
variance (ANOVA) for repeated-measures at the 95% level (p < 0.05).
SUPPLEMENTAL DATA
The Supplemental Data for this article can be found online at http://www.
neuron.org/cgi/content/full/58/6/871/DC1/.Neuron 58, 871–883, June 26, 2008 ª2008 Elsevier Inc. 881
Neuron
Presenilins Regulate InsP3R Channel GatingACKNOWLEDGMENTS
We thank Ikuo Hayashi for recombinant baculoviruses and Eric Swanson for
help with neuron isolation. This work was supported by NIH GM56328 and
MH059937 to J.K.F. and a Pilot Project from the Alzheimer’s Disease Core
Center at the University of Pennsylvania AG 10124.
Received: August 31, 2007
Revised: February 5, 2008
Accepted: April 16, 2008
Published: June 25, 2008
REFERENCES
Balaban, R.S. (2002). Cardiac energy metabolism homeostasis: role of cyto-
solic calcium. J. Mol. Cell. Cardiol. 34, 1259–1271.
Barrow, P.A., Empson, R.M., Gladwell, S.J., Anderson, C.M., Killick, R., Yu, X.,
Jefferys, J.G., and Duff, K. (2000). Functional phenotype in transgenic mice
expressing mutant human presenilin-1. Neurobiol. Dis. 7, 119–126.
Berridge, M.J., Lipp, P., and Bootman, M.D. (2000). The versatility and univer-
sality of calcium signalling. Nat. Rev. Mol. Cell Biol. 1, 11–21.
Blennow, K., de Leon, M.J., and Zetterberg, H. (2006). Alzheimer’s disease.
Lancet 368, 387–403.
Buckner, R.L., Snyder, A.Z., Shannon, B.J., LaRossa, G., Sachs, R., Fotenos,
A.F., Sheline, Y.I., Klunk, W.E., Mathis, C.A., Morris, J.C., and Mintun, M.A.
(2005). Molecular, structural, and functional characterization of Alzheimer’s
disease: evidence for a relationship between default activity, amyloid, and
memory. J. Neurosci. 25, 7709–7717.
Buxbaum, J.D., Ruefli, A.A., Parker, C.A., Cypess, A.M., and Greengard, P.
(1994). Calcium regulates processing of the Alzheimer amyloid protein precur-
sor in a protein kinase C-independent manner. Proc. Natl. Acad. Sci. USA 91,
4489–4493.
Cai, W., Hisatsune, C., Nakamura, K., Nakamura, T., Inoue, T., and Mikoshiba,
K. (2004). Activity-dependent expression of inositol 1,4,5-trisphosphate re-
ceptor type 1 in hippocampal neurons. J. Biol. Chem. 279, 23691–23698.
Cedazo-Minguez, A., Popescu, B.O., Ankarcrona, M., Nishimura, T., and Cow-
burn, R.F. (2002). The presenilin 1 deltaE9 mutation gives enhanced basal
phospholipase C activity and a resultant increase in intracellular calcium con-
centrations. J. Biol. Chem. 277, 36646–36655.
Chan, S.L., Mayne, M., Holden, C.P., Geiger, J.D., and Mattson, M.P. (2000).
Presenilin-1 mutations increase levels of ryanodine receptors and calcium re-
lease in PC12 cells and cortical neurons. J. Biol. Chem. 275, 18195–18200.
Cirrito, J.R., Yamada, K.A., Finn, M.B., Sloviter, R.S., Bales, K.R., May, P.C.,
Schoepp, D.D., Paul, S.M., Mennerick, S., and Holtzman, D.M. (2005). Synap-
tic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 48,
913–922.
Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., John-
son-Wood, K., Lee, M., Seubert, P., Davis, A., et al. (1997). Mutant presenilins
of Alzheimer’s disease increase production of 42-residue amyloid beta-protein
in both transfected cells and transgenic mice. Nat. Med. 3, 67–72.
De Strooper, B. (2007). Loss-of-function presenilin mutations in Alzheimer dis-
ease. Talking point on the role of presenilin mutations in Alzheimer disease.
EMBO Rep. 8, 141–146.
Edbauer, D., Winkler, E., Regula, J.T., Pesold, B., Steiner, H., and Haass, C.
(2003). Reconstitution of gamma-secretase activity. Nat. Cell Biol. 5, 486–488.
Etcheberrigaray, R., Hirashima, N., Nee, L., Prince, J., Govoni, S., Racchi, M.,
Tanzi, R.E., and Alkon, D.L. (1998). Calcium responses in fibroblasts from
asymptomatic members of Alzheimer’s disease families. Neurobiol. Dis. 5,
37–45.
Foskett, J.K., White, C., Cheung, K.H., and Mak, D.-O.D. (2007). Inositol tri-
sphosphate receptor Ca2+ release channels. Physiol. Rev. 87, 593–658.
Gandy, S., Doeven, M.K., and Poolman, B. (2006). Alzheimer disease: prese-
nilin springs a leak. Nat. Med. 12, 1121–1123.882 Neuron 58, 871–883, June 26, 2008 ª2008 Elsevier Inc.Genazzani, A.A., Carafoli, E., and Guerini, D. (1999). Calcineurin controls ino-
sitol 1,4,5-trisphosphate type 1 receptor expression in neurons. Proc. Natl.
Acad. Sci. USA 96, 5797–5801.
Giacomello, M., Barbiero, L., Zatti, G., Squitti, R., Binetti, G., Pozzan, T., Faso-
lato, C., Ghidoni, R., and Pizzo, P. (2005). Reduction of Ca2+ stores and capaci-
tative Ca2+ entry is associated with the familial Alzheimer’s disease presenilin-
2 T122R mutation and anticipates the onset of dementia. Neurobiol. Dis. 18,
638–648.
Guo, Q., Furukawa, K., Sopher, B.L., Pham, D.G., Xie, J., Robinson, N., Martin,
G.M., and Mattson, M.P. (1996). Alzheimer’s PS-1 mutation perturbs calcium
homeostasis and sensitizes PC12 cells to death induced by amyloid beta-pep-
tide. Neuroreport 8, 379–383.
Haass, C., and Selkoe, D.J. (2007). Soluble protein oligomers in neurodegen-
eration: lessons from the Alzheimer’s amyloid beta-peptide. Nat. Rev. Mol. Cell
Biol. 8, 101–112.
Hardy, J. (2006). A hundred years of Alzheimer’s disease research. Neuron 52,
3–13.
Hardy, J., and Selkoe, D.J. (2002). The amyloid hypothesis of Alzheimer’s
disease: progress and problems on the road to therapeutics. Science 297,
353–356.
Hebert, S.S., Serneels, L., Dejaegere, T., Horre, K., Dabrowski, M., Baert, V.,
Annaert, W., Hartmann, D., and De Strooper, B. (2004). Coordinated and wide-
spread expression of gamma-secretase in vivo: evidence for size and molec-
ular heterogeneity. Neurobiol. Dis. 17, 260–272.
Hirashima, N., Etcheberrigaray, R., Bergamaschi, S., Racchi, M., Battaini, F.,
Binetti, G., Govoni, S., and Alkon, D.L. (1996). Calcium responses in human fi-
broblasts: a diagnostic molecular profile for Alzheimer’s disease. Neurobiol.
Aging 17, 549–555.
Hutton, M., and Hardy, J. (1997). The presenilins and Alzheimer’s disease.
Hum. Mol. Genet. 6, 1639–1646.
Ionescu, L., Cheung, K.H., Vais, H., Mak, D.O., White, C., and Foskett, J.K.
(2006). Graded recruitment and inactivation of single InsP3 receptor Ca
2+-re-
lease channels: implications for quantal Ca2+ release. J. Physiol. 573, 645–662.
Ito, E., Oka, K., Etcheberrigaray, R., Nelson, T.J., McPhie, D.L., Tofel-Grehl, B.,
Gibson, G.E., and Alkon, D.L. (1994). Internal Ca2+ mobilization is altered in fi-
broblasts from patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA 91,
534–538.
Johnston, J.M., Burnett, P., Thomas, A.P., and Tezapsidis, N. (2006). Calcium
oscillations in type-1 astrocytes, the effect of a presenilin 1 (PS1) mutation.
Neurosci. Lett. 395, 159–164.
Jolly-Tornetta, C., Gao, Z.Y., Lee, V.M., and Wolf, B.A. (1998). Regulation of
amyloid precursor protein secretion by glutamate receptors in human Ntera
2 neurons. J. Biol. Chem. 273, 14015–14021.
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T.,
Sisodia, S., and Malinow, R. (2003). APP processing and synaptic function.
Neuron 37, 925–937.
Kasri, N.N., Kocks, S.L., Verbert, L., Hebert, S.S., Callewaert, G., Parys, J.B.,
Missiaen, L., and De Smedt, H. (2006). Up-regulation of inositol 1,4,5-trisphos-
phate receptor type 1 is responsible for a decreased endoplasmic-reticulum
Ca2+ content in presenilin double knock-out cells. Cell Calcium 40, 41–51.
LaFerla, F.M. (2002). Calcium dyshomeostasis and intracellular signalling in
Alzheimer’s disease. Nat. Rev. Neurosci. 3, 862–872.
Laude, A.J., Tovey, S.C., Dedos, S.G., Potter, B.V., Lummis, S.C., and Taylor,
C.W. (2005). Rapid functional assays of recombinant IP3 receptors. Cell Cal-
cium 38, 45–51.
Leissring, M.A., Parker, I., and LaFerla, F.M. (1999a). Presenilin-2 mutations
modulate amplitude and kinetics of inositol 1, 4,5-trisphosphate-mediated cal-
cium signals. J. Biol. Chem. 274, 32535–32538.
Leissring, M.A., Paul, B.A., Parker, I., Cotman, C.W., and LaFerla, F.M.
(1999b). Alzheimer’s presenilin-1 mutation potentiates inositol 1,4,5-trisphos-
phate-mediated calcium signaling in Xenopus oocytes. J. Neurochem. 72,
1061–1068.
Neuron
Presenilins Regulate InsP3R Channel GatingLeissring, M.A., Akbari, Y., Fanger, C.M., Cahalan, M.D., Mattson, M.P., and
LaFerla, F.M. (2000). Capacitative calcium entry deficits and elevated luminal
calcium content in mutant presenilin-1 knockin mice. J. Cell Biol. 149, 793–
798.
Leissring, M.A., LaFerla, F.M., Callamaras, N., and Parker, I. (2001). Subcellu-
lar mechanisms of presenilin-mediated enhancement of calcium signaling.
Neurobiol. Dis. 8, 469–478.
Lessard, C.B., Lussier, M.P., Cayouette, S., Bourque, G., and Boulay, G.
(2005). The overexpression of presenilin2 and Alzheimer’s-disease-linked pre-
senilin2 variants influences TRPC6-enhanced Ca2+ entry into HEK293 cells.
Cell. Signal. 17, 437–445.
Mak, D.-O.D., McBride, S., and Foskett, J.K. (1998). Inositol 1,4,5-trisphos-
phate activation of inositol trisphosphate receptor Ca2+ channel by ligand tun-
ing of Ca2+ inhibition. Proc. Natl. Acad. Sci. USA 95, 15821–15825.
Mattson, M.P. (2004). Pathways towards and away from Alzheimer’s disease.
Nature 430, 631–639.
Mattson, M.P., and Guo, Q. (1997). Cell and molecular neurobiology of prese-
nilins: a role for the endoplasmic reticulum in the pathogenesis of Alzheimer’s
disease? J. Neurosci. Res. 50, 505–513.
Mattson, M.P., and Chan, S.L. (2003). Neuronal and glial calcium signaling in
Alzheimer’s disease. Cell Calcium 34, 385–397.
Mattson, M.P., Zhu, H., Yu, J., and Kindy, M.S. (2000). Presenilin-1 mutation
increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and
glucose deprivation in cell culture: involvement of perturbed calcium homeo-
stasis. J. Neurosci. 20, 1358–1364.
McCormack, J.G., Halestrap, A.P., and Denton, R.M. (1990). Role of calcium
ions in regulation of mammalian intramitochondrial metabolism. Physiol.
Rev. 70, 391–425.
Meberg, P.J., and Miller, M.W. (2003). Culturing hippocampal and cortical neu-
rons. Methods Cell Biol. 71, 111–127.
Nelson, O., Tu, H., Lei, T., Bentahir, M., de Strooper, B., and Bezprozvanny, I.
(2007). Familial Alzheimer disease-linked mutations specifically disrupt Ca2+
leak function of presenilin 1. J. Clin. Invest. 117, 1230–1239.
Oh, Y.S., and Turner, R.J. (2006). Effect of gamma-secretase inhibitors on
muscarinic receptor-mediated calcium signaling in human salivary epithelial
cells. Am. J. Physiol. Cell Physiol. 291, C76–C82.
Querfurth, H.W., and Selkoe, D.J. (1994). Calcium ionophore increases amy-
loid beta peptide production by cultured cells. Biochemistry 33, 4550–4561.
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird,
T.D., Hardy, J., Hutton, M., Kukull, W., et al. (1996). Secreted amyloid beta-
protein similar to that in the senile plaques of Alzheimer’s disease is increased
in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alz-
heimer’s disease. Nat. Med. 2, 864–870.
Schneider, I., Reverse, D., Dewachter, I., Ris, L., Caluwaerts, N., Kuiperi, C.,
Gilis, M., Geerts, H., Kretzschmar, H., Godaux, E., et al. (2001). Mutant prese-
nilins disturb neuronal calcium homeostasis in the brain of transgenic mice,
decreasing the threshold for excitotoxicity and facilitating long-term potentia-
tion. J. Biol. Chem. 276, 11539–11544.
Shen, J., and Kelleher, R.J., 3rd. (2007). The presenilin hypothesis of Alz-
heimer’s disease: evidence for a loss-of-function pathogenic mechanism.
Proc. Natl. Acad. Sci. USA 104, 403–409.
Smith, I.F., Boyle, J.P., Vaughan, P.F., Pearson, H.A., Cowburn, R.F., and
Peers, C.S. (2002). Ca2+ stores and capacitative Ca2+ entry in human neuro-blastoma (SH-SY5Y) cells expressing a familial Alzheimer’s disease preseni-
lin-1 mutation. Brain Res. 949, 105–111.
Smith, I.F., Green, K.N., and LaFerla, F.M. (2005a). Calcium dysregulation in
Alzheimer’s disease: recent advances gained from genetically modified ani-
mals. Cell Calcium 38, 427–437.
Smith, I.F., Hitt, B., Green, K.N., Oddo, S., and LaFerla, F.M. (2005b). En-
hanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alz-
heimer’s disease. J. Neurochem. 94, 1711–1718.
Stutzmann, G.E. (2005). Calcium dysregulation, IP3 signaling, and Alzheimer’s
disease. Neuroscientist 11, 110–115.
Stutzmann, G.E., Caccamo, A., LaFerla, F.M., and Parker, I. (2004). Dysregu-
lated IP3 signaling in cortical neurons of knock-in mice expressing an Alz-
heimer’s-linked mutation in presenilin1 results in exaggerated Ca2+ signals
and altered membrane excitability. J. Neurosci. 24, 508–513.
Stutzmann, G.E., Smith, I., Caccamo, A., Oddo, S., Laferla, F.M., and Parker, I.
(2006). Enhanced ryanodine receptor recruitment contributes to Ca2+ disrup-
tions in young, adult, and aged Alzheimer’s disease mice. J. Neurosci. 26,
5180–5189.
Sugawara, H., Kurosaki, M., Takata, M., and Kurosaki, T. (1997). Genetic evi-
dence for involvement of type 1, type 2 and type 3 inositol 1,4,5-trisphosphate
receptors in signal transduction through the B-cell antigen receptor. EMBO J.
16, 3078–3088.
Supnet, C., Grant, J., Kong, H., Westaway, D., and Mayne, M. (2006). Amyloid-
beta-(1–42) increases ryanodine receptor-3 expression and function in neu-
rons of TgCRND8 mice. J. Biol. Chem. 281, 38440–38447.
Suzuki, N., Cheung, T.T., Cai, X.D., Odaka, A., Otvos, L., Jr., Eckman, C.,
Golde, T.E., and Younkin, S.G. (1994). An increased percentage of long amy-
loid beta protein secreted by familial amyloid beta protein precursor (beta
APP717) mutants. Science 264, 1336–1340.
Takeda, T., Asahi, M., Yamaguchi, O., Hikoso, S., Nakayama, H., Kusakari, Y.,
Kawai, M., Hongo, K., Higuchi, Y., Kashiwase, K., et al. (2005). Presenilin 2 reg-
ulates the systolic function of heart by modulating Ca2+ signaling. FASEB J. 19,
2069–2071.
Tu, H., Nelson, O., Bezprozvanny, A., Wang, Z., Lee, S.F., Hao, Y.H., Serneels,
L., De Strooper, B., Yu, G., and Bezprozvanny, I. (2006). Presenilins form ER
Ca2+ leak channels, a function disrupted by familial Alzheimer’s disease-linked
mutations. Cell 126, 981–993.
Verkhratsky, A. (2005). Physiology and pathophysiology of the calcium store in
the endoplasmic reticulum of neurons. Physiol. Rev. 85, 201–279.
White, C., Li, C., Yang, J., Petrenko, N.B., Madesh, M., Thompson, C.B., and
Foskett, J.K. (2005). The endoplasmic reticulum gateway to apoptosis by Bcl-
XL modulation of the InsP3R. Nat. Cell Biol. 7, 1021–1028.
Yoo, A.S., Cheng, I., Chung, S., Grenfell, T.Z., Lee, H., Pack-Chung, E., Han-
dler, M., Shen, J., Xia, W., Tesco, G., et al. (2000). Presenilin-mediated modu-
lation of capacitative calcium entry. Neuron 27, 561–572.
Zatti, G., Ghidoni, R., Barbiero, L., Binetti, G., Pozzan, T., Fasolato, C., and
Pizzo, P. (2004). The presenilin 2 M239I mutation associated with familial Alz-
heimer’s disease reduces Ca2+ release from intracellular stores. Neurobiol.
Dis. 15, 269–278.
Zatti, G., Burgo, A., Giacomello, M., Barbiero, L., Ghidoni, R., Sinigaglia, G.,
Florean, C., Bagnoli, S., Binetti, G., Sorbi, S., et al. (2006). Presenilin mutations
linked to familial Alzheimer’s disease reduce endoplasmic reticulum and Golgi
apparatus calcium levels. Cell Calcium 39, 539–550.Neuron 58, 871–883, June 26, 2008 ª2008 Elsevier Inc. 883
